Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey
- PMID: 24698853
- PMCID: PMC4263934
- DOI: 10.1093/ajh/hpu053
Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey
Abstract
Background: Hypertension is one of the major risk factor for cardiovascular disease worldwide. The objective of this study was to investigate the prevalence, awareness, treatment, and control of hypertension in China.
Methods: A multistage, stratified sampling method was used to obtain a representative sample of persons aged 18 years or older in the general population of China. Blood pressure (BP) was measured by sphygmomanometer 3 times at 5-minute intervals. Hypertension was defined as a systolic BP ≥ 140mm Hg, or diastolic BP ≥ 90mm Hg, or self-reported use of antihypertensive medications in the last 2 weeks irrespective of the BP.
Results: Altogether 50,171 subjects finished the survey across the entire country. The adjusted prevalence of hypertension was 29.6% (95% confidence interval (CI) = 28.9%-30.4%) and was higher among men than among women (31.2%, 95% CI = 30.1%-32.4%; vs. 28.0%, 95% CI = 27.0%-29.0%). The awareness, treatment among all hypertensive participants, control among all hypertensive participants, and control among treated hypertensive participants were 42.6%, 34.1%, 9.3%, and 27.4%, respectively. Multiple lifestyle factors were independently associated with presence of hypertension, including physical inactivity, habitual drinking, chronic use of nonsteroidal anti-inflammatory drugs, high body mass index, and central obesity.
Conclusions: Hypertension is an important public health burden in China, and control of hypertension is still suboptimal. Several modifiable lifestyle activities were associated with hypertension and thus should be considered potential targets for intervention, with special attention to socioeconomically disadvantaged subpopulations in China.
Keywords: China; blood pressure; epidemiology; hypertension; prevalence..
© American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Figures
Comment in
-
Hypertension control prevalence estimates should account for age.Am J Hypertens. 2014 Nov;27(11):1426. doi: 10.1093/ajh/hpu166. Am J Hypertens. 2014. PMID: 25293937 Free PMC article. No abstract available.
-
Response to "hypertension control prevalence estimates should account for age".Am J Hypertens. 2014 Nov;27(11):1427. doi: 10.1093/ajh/hpu169. Am J Hypertens. 2014. PMID: 25293938 Free PMC article. No abstract available.
References
-
- Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217–223. - PubMed
-
- Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21:1983–1992. - PubMed
-
- Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, Woodward M, Li X, Chalmers J, Gao R, Kong L, Yang X; for the China NNHS Steering. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118:2679–2686. - PubMed
-
- Ma WJ, Tang JL, Zhang YH, Xu YJ, Lin JY, Li JS, Lao XQ, Tam WW, Wong MC, Yu IT. Hypertension prevalence, awareness, treatment, control, and associated factors in adults in southern China. Am J Hypertens 2012; 25:590–596. - PubMed
-
- He J, Gu D, Chen J, Wu X, Kelly TN, Huang JF, Chen JC, Chen CS, Bazzano LA, Reynolds K, Whelton PK, Klag MJ. Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet 2009; 374:1765–1772. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
